Miyako Capital is a private equity firm that specializes in early-stage investments.
Business Model:
Revenue: $364.7k
Employees: 2-10
Address:
City:
State:
Zip:
Country:
Miyako Capital is a private equity firm that specializes in early-stage investments.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2021 | VividQ | Seed Round | 15.1M |
10/2017 | Institution for a Global Society | Corporate Round | 2.2M |
7/2015 | Farmship | Venture Round | 805.9k |
4/2014 | MONEY DESIGN | Seed Round | 917.9k |
11/2019 | GORYO Chemical | Venture Round | 9.6M |
3/2019 | Integral Geometry Science | Venture Round | 6.8M |
10/2020 | Floadia Corporation | Series C | 0 |
12/2017 | Megakaryon Corporation | Series C | 0 |
9/2019 | Integral Geometry Science | Venture Round | 4.6M |
5/2017 | REGiMMUNE | Series E | 5.7M |
11/2020 | HACARUS | Series B | 12.4M |
5/2016 | Kyoto Drug Discovery &a; Development | Seed Round | 7.6M |
11/2014 | Nota | Series A | 2M |
6/2016 | Integral Geometry Science | Venture Round | 1.4M |
4/2020 | Liberaware | Venture Round | 0 |
3/2021 | VLP Therapeutics | Series A | 0 |
7/2019 | Atomis | Series A | 3.2M |
5/2016 | AFI Japan | Series A | 2.6M |
9/2014 | iHeart Japan | Series A | 1.9M |
9/2020 | CellAxia | Series B | 0 |
7/2018 | ARTham Therapeutics | Series A | - |
4/2020 | BizteX | Series C | 0 |
3/2015 | Megakaryon Corporation | Series B | 21.2M |
3/2017 | FLOSFIA | Venture Round | 6.6M |
4/2018 | Trigence | Series C | - |
11/2017 | StemRIM | Venture Round | 9M |
12/2018 | StemRIM | Venture Round | 6.8M |
3/2017 | Drivemode | Series A | 6.5M |
5/2021 | Startbahn | Series B | 10.2M |
12/2021 | VLP Therapeutics | Series A | 0 |
9/2020 | Varinos | Seed Round | 2.8M |
10/2016 | HACARUS | Seed Round | 394.7k |
3/2022 | Social Good Foundation Inc. | Series A | 14.2M |
10/2018 | HACARUS | Series A | 2.4M |
3/2022 | Social Good Foundation Inc. | Series A | 0 |
12/2021 | VLP Therapeutics | Series A | 0 |
7/2021 | VividQ | Seed Round | 0 |
5/2021 | Startbahn | Series B | 0 |
3/2021 | VLP Therapeutics | Series A | 0 |
11/2020 | HACARUS | Series B | 0 |
10/2020 | Floadia Corporation | Series C | 0 |
9/2020 | Varinos | Seed Round | 0 |
9/2020 | CellAxia | Series B | 0 |
4/2020 | Liberaware | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|